Epidemiology and risk profile of heart failure
- PMID: 21060326
- PMCID: PMC3033496
- DOI: 10.1038/nrcardio.2010.165
Epidemiology and risk profile of heart failure
Abstract
Heart failure (HF) is a major public health issue, with a prevalence of over 5.8 million in the USA, and over 23 million worldwide, and rising. The lifetime risk of developing HF is one in five. Although promising evidence shows that the age-adjusted incidence of HF may have plateaued, HF still carries substantial morbidity and mortality, with 5-year mortality that rival those of many cancers. HF represents a considerable burden to the health-care system, responsible for costs of more than $39 billion annually in the USA alone, and high rates of hospitalizations, readmissions, and outpatient visits. HF is not a single entity, but a clinical syndrome that may have different characteristics depending on age, sex, race or ethnicity, left ventricular ejection fraction (LVEF) status, and HF etiology. Furthermore, pathophysiological differences are observed among patients diagnosed with HF and reduced LVEF compared with HF and preserved LVEF, which are beginning to be better appreciated in epidemiological studies. A number of risk factors, such as ischemic heart disease, hypertension, smoking, obesity, and diabetes, among others, have been identified that both predict the incidence of HF as well as its severity. In this Review, we discuss key features of the epidemiology and risk profile of HF.
Conflict of interest statement
G. C. Fonarow declares associations with the following companies: Bristol-Myers Squibb/Sanofi, GlaxoSmithKline, Medtronic, Merck, Novartis, and Pfizer. See the article online for full details of the relationships. A. L. Bui and T. B. Horwich declare no competing interests.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3033496/bin/nihms261324f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3033496/bin/nihms261324f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3033496/bin/nihms261324f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3033496/bin/nihms261324f4.gif)
Similar articles
-
Sex Differences in Heart Failure.Adv Exp Med Biol. 2018;1065:529-544. doi: 10.1007/978-3-319-77932-4_32. Adv Exp Med Biol. 2018. PMID: 30051405 Review.
-
Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings.Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):820-828. doi: 10.1016/j.rec.2017.10.030. Epub 2017 Dec 15. Rev Esp Cardiol (Engl Ed). 2018. PMID: 29249471 English, Spanish.
-
Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.JACC Cardiovasc Imaging. 2018 Jan;11(1):1-11. doi: 10.1016/j.jcmg.2017.08.007. Epub 2017 Oct 5. JACC Cardiovasc Imaging. 2018. PMID: 28917679 Free PMC article.
-
Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.Clin Res Cardiol. 2017 May;106(5):359-368. doi: 10.1007/s00392-016-1063-0. Epub 2016 Dec 20. Clin Res Cardiol. 2017. PMID: 27999929
-
Epidemiology and aetiology of heart failure.Nat Rev Cardiol. 2016 Jun;13(6):368-78. doi: 10.1038/nrcardio.2016.25. Epub 2016 Mar 3. Nat Rev Cardiol. 2016. PMID: 26935038 Free PMC article. Review.
Cited by
-
Blood pressure and heart failure: focused on treatment.Clin Hypertens. 2024 Jun 1;30(1):15. doi: 10.1186/s40885-024-00271-y. Clin Hypertens. 2024. PMID: 38822445 Free PMC article. Review.
-
m6A reader YTHDF1 promotes cardiac fibrosis by enhancing AXL translation.Front Med. 2024 Jun;18(3):499-515. doi: 10.1007/s11684-023-1052-4. Epub 2024 May 28. Front Med. 2024. PMID: 38806989
-
Machine learning-based analysis of non-invasive measurements for predicting intracardiac pressures.Eur Heart J Digit Health. 2024 Mar 13;5(3):288-294. doi: 10.1093/ehjdh/ztae021. eCollection 2024 May. Eur Heart J Digit Health. 2024. PMID: 38774375 Free PMC article.
-
Danicamtiv affected isometric force and cross-bridge kinetics similarly in skinned myocardial strips from male and female rats.J Muscle Res Cell Motil. 2024 May 8. doi: 10.1007/s10974-024-09669-5. Online ahead of print. J Muscle Res Cell Motil. 2024. PMID: 38717549
-
Potential Application of Modified mRNA in Cardiac Regeneration.Cell Transplant. 2024 Jan-Dec;33:9636897241248956. doi: 10.1177/09636897241248956. Cell Transplant. 2024. PMID: 38715279 Free PMC article. Review.
References
-
- Lloyd-Jones D, et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–e215. - PubMed
-
- McMurray JJ, Petrie MC, Murdoch DR, Davie AP. Clinical epidemiology of heart failure: public and private health burden. Eur Heart J. 1998;19 (Suppl P):P9–P16. - PubMed
-
- Levy D, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402. - PubMed
-
- Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301–306. - PubMed
-
- Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008;52:428–434. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous